Who
Jonathan E. Freeman
Director
Company insider
Files Form 4 as: Director, Phio Pharmaceuticals.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 6 Jun 2017
- Last trade
- 5 Feb 2026
- Last filed
- 6 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Feb 2026filed 6 Feb 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —16,600 at $0.00 | filing |
| 5 Feb 2026filed 6 Feb 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —16,600 at $0.00 | filing |
| 11 Sep 2025filed 15 Sep 2025 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —14,700 at $0.00 | filing |
| 11 Sep 2024filed 13 Sep 2024 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —1,000 at $0.00 | filing |
| 17 Feb 2023filed 22 Feb 2023 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 15 Feb 2022filed 16 Feb 2022 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 1 Mar 2021filed 3 Mar 2021 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 13 Feb 2019filed 15 Feb 2019 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 1 Aug 2018filed 3 Aug 2018 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 6 Jun 2017filed 7 Jun 2017 | PHIO Phio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.